Higginbottom A - Search Results

1

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Higginbottom A, Quinn ER, Kuo CC, Flint M, Wilson LH, Bianchi E, Nicosia A, Monk PN, McKeating JA, Levy S. Higginbottom A, et al. J Virol. 2000 Apr;74(8):3642-9. doi: 10.1128/jvi.74.8.3642-3649.2000. J Virol. 2000. PMID: 10729140 Free PMC article.

2

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, Monk P, Higginbottom A, Levy S, McKeating JA. Flint M, et al. Among authors: higginbottom a. J Virol. 1999 Aug;73(8):6235-44. doi: 10.1128/JVI.73.8.6235-6244.1999. J Virol. 1999. PMID: 10400713 Free PMC article.

3

Antibody cross-linking of human CD9 and the high-affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells.

Higginbottom A, Wilkinson I, McCullough B, Lanza F, Azorsa DO, Partridge LJ, Monk PN. Higginbottom A, et al. Immunology. 2000 Apr;99(4):546-52. doi: 10.1046/j.1365-2567.2000.00992.x. Immunology. 2000. PMID: 10792502 Free PMC article.

4

Characterisation of C5a receptor agonists from phage display libraries.

Cain SA, Higginbottom A, Monk PN. Cain SA, et al. Among authors: higginbottom a. Biochem Pharmacol. 2003 Nov 1;66(9):1833-40. doi: 10.1016/s0006-2952(03)00473-8. Biochem Pharmacol. 2003. PMID: 14563493

5

Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion.

Higginbottom A, Takahashi Y, Bolling L, Coonrod SA, White JM, Partridge LJ, Monk PN. Higginbottom A, et al. Biochem Biophys Res Commun. 2003 Nov 7;311(1):208-14. doi: 10.1016/j.bbrc.2003.09.196. Biochem Biophys Res Commun. 2003. PMID: 14575715

6

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. Zhang J, et al. Among authors: higginbottom a. J Virol. 2004 Feb;78(3):1448-55. doi: 10.1128/jvi.78.3.1448-1455.2004. J Virol. 2004. PMID: 14722300 Free PMC article.

7

Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation.

Barreiro O, Yáñez-Mó M, Sala-Valdés M, Gutiérrez-López MD, Ovalle S, Higginbottom A, Monk PN, Cabañas C, Sánchez-Madrid F. Barreiro O, et al. Among authors: higginbottom a. Blood. 2005 Apr 1;105(7):2852-61. doi: 10.1182/blood-2004-09-3606. Epub 2004 Dec 9. Blood. 2005. PMID: 15591117 Free article.

8

Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.

Higginbottom A, Cain SA, Woodruff TM, Proctor LM, Madala PK, Tyndall JD, Taylor SM, Fairlie DP, Monk PN. Higginbottom A, et al. J Biol Chem. 2005 May 6;280(18):17831-40. doi: 10.1074/jbc.M410797200. Epub 2005 Jan 20. J Biol Chem. 2005. PMID: 15661745 Free article.

9

Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.

Ho SH, Martin F, Higginbottom A, Partridge LJ, Parthasarathy V, Moseley GW, Lopez P, Cheng-Mayer C, Monk PN. Ho SH, et al. Among authors: higginbottom a. J Virol. 2006 Jul;80(13):6487-96. doi: 10.1128/JVI.02539-05. J Virol. 2006. PMID: 16775336 Free PMC article.

10

The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.

Scola AM, Higginbottom A, Partridge LJ, Reid RC, Woodruff T, Taylor SM, Fairlie DP, Monk PN. Scola AM, et al. Among authors: higginbottom a. J Biol Chem. 2007 Feb 9;282(6):3664-71. doi: 10.1074/jbc.M609178200. Epub 2006 Dec 11. J Biol Chem. 2007. PMID: 17158873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters